Multifocal Motor Neuropathy Clinical Trial
Official title:
A Multicenter Prospective Longitudinal Study of Clinical Outcomes, Disease Course, Health-Related Quality of Life, and Health Care Resource Utilization in Adult Patients With Multifocal Motor Neuropathy
This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06040567 -
Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
|
||
Not yet recruiting |
NCT02885259 -
HyQvia in Multifocal Motor Neuropathy
|
N/A | |
Active, not recruiting |
NCT01655394 -
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
|
N/A | |
Active, not recruiting |
NCT05225675 -
A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy
|
Phase 2 | |
Completed |
NCT02556437 -
Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)
|
Phase 2 | |
Completed |
NCT02111590 -
Immunoglobulin Dosage and Administration Form in CIDP and MMN
|
N/A | |
Completed |
NCT00666263 -
Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy
|
Phase 3 | |
Completed |
NCT00268788 -
Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
|
Phase 2 | |
Completed |
NCT02121678 -
Effect of Resistance and Aerobic Exercise in CIDP or MMN
|
N/A | |
Completed |
NCT01827072 -
Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.
|
Phase 3 |